Page 15 - Indian Equities

RedTape share price jumps 5% on rolling out this product; details inside

Around 12:00 PM, RedTape share price was trading 3.61 per cent higher at ₹136.50 per share. In comparison, BSE Sensex was trading 0.31 per cent higher at 84,894.55 levels.

Robust Q2, GST tailwind lift M&M Fin to 52-wk high; analysts raise targets

While earnings came in ahead of expectations for M&M Financial Services, analysts remain watchful of persistently high credit costs and moderation in asset growth.

Strong Q2, EV gains power bullish view on TVS Motor Company; targets raised

The Street expects TVS Motor's consistent outperformance, new launches, and EV traction to sustain earnings momentum, even as some brokerage houses flag valuation concerns.

SRF's chemicals biz leads Q2 growth; analysts stay bullish; check targets

Brokerages maintained a positive stance on SRF, highlighting continued margin strength, steady volume growth, and the company's strategic capex expansion.

Stock Market close: Sensex down 150 pts, Nifty at 25,936; PSU Bank, Metal indices up 1%; Realty drag

Sensex Today | Stock Market close: In the broader market, the Nifty MidCap index and the Nifty SmallCap index settled almost flat

Hyundai India Q2 preview: Margins seen rising on richer mix, cost control

On the bourses at 2:05 PM, Hyundai Motor India share price was trading 1.31 per cent higher at 2,302.50. By comparison, BSE Sensex was trading 0.48 per cent lower at 84,370.08 levels.

Target @₹7,000: IndiGo set to fly higher as Anand Rathi initiates with Buy

Anand Rathi believes IndiGo's disciplined low-cost structure, commanding market share, and strategic global expansion make it a long-term compounding story in Indian aviation.

Mazagon up 3% on healthy Q2 show; declares ₹6 dividend; check record date

Mazagon Dock Shipbuilders' shares rose after the company reported strong financial performance for the September quarter of FY26 (Q2FY26).

PNB Housing delivers steady Q2; analysts bullish on growth, margin outlook

On the bourses around 9:30 AM, PNB Housing share was trading flat at ₹927.45 apiece. By comparison, BSE Sensex was trading marginally higher at 84,792.25 levels.

Sona BLW's diversified growth drivers impress brokerages; Nomura ups target

Sona BLW's revenue jumped 24 per cent year-on-year (Y-o-Y) to ₹1,140 crore, exceeding the brokerage's forecast of ₹1,070 crore.

Stock Market close: Sensex jumps 567 pts; Nifty at 25,966; PSU bank, realty stocks lead gains

Sensex Today | Stock Market close: In the broader market, the Nifty MidCap and the Nifty SmallCap index added 0.93 per cent and 0.82 per cent respectively

InCred Equities upgrades Tata Steel to 'Add'; stock hits fresh 52-week high

On the bourses, Tata Steel shares rose as much as 1.91 per cent to hit a fresh 52-week high of ₹177.85 per share.

NCC share up 3% on securing orders worth ₹6,829 cr from Central Coalfields

NCC share price moved northwards after securing an order worth approximately ₹6,828.94 crore from Central Coalfields.

Steady growth, firm margins lift SBI Life to 52-wk high; analysts keep Buy

At 10 AM, SBI Life share price continued to trade in the northward direction, up 3.37 per cent at ₹1,902.60 per share. By comparison, BSE Sensex was trading 0.57 per cent higher at 84,695.60 levels.

Coforge gains 6% as analysts turn bullish after Q2, see up to 36% upside

On the bourses, Coforge share price zoomed up to 5.98 per cent to hit an intraday high of ₹1,866 per share post Q2 results.

Brokerages see near-term upside in Dr Reddy's on Semaglutide, ex-US growth

Dr Reddy's Laboratories reported a consolidated Q2FY26 net profit of ₹1,437.2 crore, up 14 per cent Y-o-Y from ₹1,255.3 crore, with sequential growth largely flat.

Double whammy hits Colgate: GST cuts, competition weigh on Q2 sales

Analysts largely agree that the toothpaste major's volumes and revenue were hit by a 'double whammy' of GST rate cuts and intensifying competition, with limited signs of a near-term recovery.

Nuvama retains 'Hold' on Cipla, raises target after Eli Lilly diabetes deal

Cipla- Eli Lilly deal: Tirzepatide is a prescription drug used for managing type 2 diabetes and aiding weight loss in adults who are obese or overweight.

Why did Garuda Construction share price zoom 9% in trade today? Find here

Garuda Construction share price zoomed after the company announced that it has secured a construction order worth ₹231 crore.

Jain Resource Recycling share zooms 9%, hits record high on strong Q2 show

By 11 AM, Jain Resource share price was off record high, but continued to trade 3.43 per cent higher at ₹368 per share. In comparison, BSE Sensex was trading 0.76 per cent higher at 85,070.29 levels.